Biology Reference
In-Depth Information
Brehm A, Nielsen SJ, Miska EA, McCance DJ, Reid JL, Bannister AJ, Kouzarides T (1999) The
E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth.
EMBO J 18:2449-2458
Cunha-Ferreira I, Rodrigues-Martins A, Bento I, Riparbelli M, Zhang W, Laue E, Callaini G,
Glover DM, Bettencourt-Dias M (2009) The SCF/Slimb ubiquitin ligase limits centrosome
amplification through degradation of SAK/PLK4. Curr Biol 19:43-49
de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H (2004) Classification of
papillomaviruses. Virology 324:17-27
Doorbar J, Ely S, Sterling J, McLean C, Crawford L (1991) Specific interaction between HPV-16
E1-E4 and cytokeratins results in collapse of the epithelial cell intermediate filament network.
Nature 352:824-827
Duensing S, Munger K (2002) The human papillomavirus type 16 E6 and E7 oncoproteins
independently induce numerical and structural chromosome instability. Cancer Res 62:7075-
7082
Duensing S, Munger K (2003) Human papillomavirus type 16 E7 oncoprotein can induce
abnormal centrosome
duplication
through a mechanism independent
of inactivation of
retinoblastoma protein family members. J Virol 77:12331-12335
Duensing S, Munger K (2004) Mechanisms of genomic instability in human cancer: insights from
studies with human papillomavirus oncoproteins. Int J Cancer 109:157-162
Duensing S, Lee LY, Duensing A, Basile J, Piboonniyom S, Gonzalez S, Crum CP, Munger K
(2000) The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce
mitotic defects and genomic instability by uncoupling centrosome duplication from the cell
division cycle. Proc Natl Acad Sci U S A 97:10002-10007
Duensing S, Duensing A, Crum CP, Munger K (2001a) Human papillomavirus type 16 E7
oncoprotein-induced
abnormal
centrosome
synthesis
is
an early
event
in
the
evolving
malignant phenotype. Cancer Res 61:2356-2360
Duensing S, Duensing A, Flores ER, Do A, Lambert PF, Munger K (2001b) Centrosome
abnormalities and genomic instability by episomal expression of human papillomavirus type
16 in raft cultures of human keratinocytes. J Virol 75:7712-7716
Duensing A, Liu Y, Perdreau SA, Kleylein-Sohn J, Nigg EA, Duensing S (2007a) Centriole
overduplication through the concurrent formation of multiple daughter centrioles at single
maternal templates. Oncogene 26:6280-6288
Duensing A, Liu Y, Spardy N, Bartoli K, Tseng M, Kwon JA, Teng X, Duensing S (2007b) RNA
polymerase
II
transcription
is
required
for
human
papillomavirus
type
16
E7-
and
hydroxyurea-induced centriole overduplication. Oncogene 26:215-223
Duensing A, Chin A, Wang L, Kuan SF, Duensing S (2008) Analysis of centrosome
overduplication in correlation to cell division errors in high-risk human papillomavirus
(HPV)-associated anal neoplasms. Virology 372:157-164
Dyson N, Howley PM, Munger K, Harlow E (1989) The human papilloma virus-16 E7
oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934-937
Freed
E,
Lacey
KR,
Huie
P,
Lyapina
SA,
Deshaies
RJ,
Stearns
T,
Jackson
PK
(1999)
Components
of
an
SCF
ubiquitin
ligase
localize
to
the
centrosome
and
regulate
the
centrosome duplication cycle. Genes Dev 13:2242-2257
Frisch SM, Screaton RA (2001) Anoikis mechanisms. Curr Opin Cell Biol 13:555-562
Funk JO, Waga S, Harry JB, Espling E, Stillman B, Galloway DA (1997) Inhibition of CDK
activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the
HPV-16 E7 oncoprotein. Genes Dev 11:2090-2100
Gardiol D, Kuhne C, Glaunsinger B, Lee SS, Javier R, Banks L (1999) Oncogenic human
papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated
degradation. Oncogene 18:5487-5496
Gewin L, Myers H, Kiyono T, Galloway DA (2004) Identification of a novel telomerase repressor
that
interacts
with
the human
papillomavirus
type-16
E6/E6-AP
complex.
Genes
Dev
18:2269-2282
